Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization

Details for Australian Patent Application No. 2010256921 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Kim, Soojin

Agent Spruson & Ferguson

Pub. Number AU-A-2010256921

PCT Pub. Number WO2010/141333

Priority 61/183,615 03.06.09 US

Filing date 28 May 2010

Wipo publication date 9 December 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/141333 Priority application(s): WO2010/141333

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010256930-Method and system for directing a localized biological response to an implant

2010256915-Downhole magnetic measurement while rotating and methods of use